| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.0034 | 1 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |